These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use. Mirakhur RK Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013 [TBL] [Abstract][Full Text] [Related]
24. Research and development of aminosteroid neuromuscular blocking agents: past and future. Marshall RJ; Muir AW; Sleigh T; Savage DS Eur J Anaesthesiol Suppl; 1995 Sep; 11():5-10. PubMed ID: 8557007 [TBL] [Abstract][Full Text] [Related]
25. [The importance of neuromuscular monitoring during anesthesia for neuroradiologic diagnosis]. Schönstedt R; Böhrer H Anaesthesiol Reanim; 1993; 18(2):53-6. PubMed ID: 8397672 [TBL] [Abstract][Full Text] [Related]
26. Rapacuronium bromide: a review of its use in anaesthetic practice. Onrust SV; Foster RH Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867 [TBL] [Abstract][Full Text] [Related]
27. Pharmacology of neuromuscular blocking agents in the intensive care unit. Hanson CW Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926 [TBL] [Abstract][Full Text] [Related]
28. Neuromuscular blocking agents in the neurosurgical intensive care unit. Ohlinger MJ; Rhoney DH Surg Neurol; 1998 Feb; 49(2):217-21. PubMed ID: 9457275 [TBL] [Abstract][Full Text] [Related]
29. Muscle relaxants suitable for day case surgery. Geldner G; Wulf H Eur J Anaesthesiol Suppl; 2001; 23():43-6. PubMed ID: 11766246 [TBL] [Abstract][Full Text] [Related]
30. The importance of myorelaxants in anesthesia. Flood P Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920 [TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships among derivatives of dicarboxylic acid esters of tropine. Gyermek L Pharmacol Ther; 2002 Oct; 96(1):1-21. PubMed ID: 12441175 [TBL] [Abstract][Full Text] [Related]
32. [Newly developed muscle relaxants]. Fukushima K Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579 [No Abstract] [Full Text] [Related]
33. "Train-of-four" fade during clinical nondepolarizing neuromuscular block. Gyermek L; Berman N Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):122-7. PubMed ID: 1533392 [TBL] [Abstract][Full Text] [Related]
34. Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments. Savarese JJ; Antonio RP; Ginsburg S Anesth Analg; 1975; 54(5):669-78. PubMed ID: 126651 [TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent. Larijani GE; Zafeiridis A; Goldberg ME Pharmacotherapy; 1999 Oct; 19(10):1118-22. PubMed ID: 10512060 [TBL] [Abstract][Full Text] [Related]
36. The neuromuscular blocking drugs. Torda TA Med J Aust; 1988 Sep; 149(6):316-9. PubMed ID: 2843731 [No Abstract] [Full Text] [Related]
37. Bis- and mixed-tetrahydroisoquinolinium chlorofumarates: new ultra-short-acting nondepolarizing neuromuscular blockers. Boros EE; Bigham EC; Boswell GE; Mook RA; Patel SS; Savarese JJ; Ray JA; Thompson JB; Hashim MA; Wisowaty JC; Feldman PL; Samano V J Med Chem; 1999 Jan; 42(2):206-9. PubMed ID: 9925724 [No Abstract] [Full Text] [Related]
38. Clinical pharmacology of neuromuscular blocking agents. Fisher DM Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S4-9. PubMed ID: 10437710 [TBL] [Abstract][Full Text] [Related]
39. Neuromuscular blockade in the elderly. Stankiewicz-Rudnicki M Anaesthesiol Intensive Ther; 2016; 48(4):257-260. PubMed ID: 27797097 [TBL] [Abstract][Full Text] [Related]